Drug Profile
ARR 12495AA
Alternative Names: FPL 12495AALatest Information Update: 22 Jan 2007
Price :
$50
*
At a glance
- Originator AstraZeneca R&D Charnwood
- Class Analgesics; Antiepileptic drugs; Antirheumatics; Neuroprotectants
- Mechanism of Action Glutamate receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Inflammation; Pain